Indexed by:
Abstract:
氢分子液体/气体在制备抑制肿瘤干细胞药物中的应用,属于制备抑制肿瘤干细胞药物技术领域。将含有氢分子的液体/气体用于制备抑制肿瘤干细胞药物,显著抑制肿瘤体内成瘤能力,使得肿瘤细胞的侵袭能力显著下降,进一步显著抑制肿瘤干细胞表面标记CD133的表达,而促进分化标记的表达。
Keyword:
Reprint Author's Address:
Email:
Patent Info :
Type: 发明申请
Patent No.: CN201710416699.3
Filing Date: 2017-06-06
Publication Date: 2017-10-24
Pub. No.: CN107281214A
Applicants: 北京工业大学
Legal Status: 撤回-视为撤回
Cited Count:
WoS CC Cited Count: 0
SCOPUS Cited Count:
ESI Highly Cited Papers on the List: 0 Unfold All
WanFang Cited Count:
Chinese Cited Count:
30 Days PV: 6
Affiliated Colleges: